CRISPR based Gene Therapy Training

BDG LifeSciences is a distinguished bioinformatics company established in 2010 and operates globally. Headquartered in India the company specializes in facilitating workshops, training programs, novel & innovative research projects, and online courses in technologies of bioinformatics & life science. The company is registered under the Ministry of MSME (Micro, Small, and Medium Enterprises), Government of India, with the registration number UDYAM-UP-01-0019151. Recently, BDG Lifesciences, India has authorized BBR Group Pty Ltd., Australia (ACN 608 550 849), to operate its programs in Australia & New Zealand.

With a focus on practical application of technology, where participants work on their own computer/laptop on software/servers, BDG LifeSciences has been a leader in the sector for the last 14 years.

Since its inception, BDG LifeSciences has successfully educated a diverse range of participants globally, including students, scientists, faculty members, professors, and corporate executives.

To view the pictures of our previous events click here-1 and click here-2. To view, the listing of upcoming events kindly click here and our previous workshops can be viewed here. To view the video feedback of our previous events kindly visit our YouTube Channel

We are the first to launch a workshop and training course (Online & Onsite) on CRISPR/Cas 9 in May 2017 and since then did it successfully several times. Now advancing in the technology we have launched a 5-day complete hands-on Online Workshop in CRISPR based Gene Therapy. Currently, CRISPR/Cas9 based Genome Editing is becoming one of the most promising tools for treating human genetic diseases, including cardiovascular diseases, neuro-disorders, and cancers.  CRISPR technology is 80% wet lab and 20% computational, we cover the computational part. It will be an extensive hands-on training program in which participants will run the processes (insilico) on their own computer systems with complete learning of this revolutionary technology. Video recording of each session will be provided at the end of the session to give the user a unique learning experience. On successful completion of the course participation certificate will be awarded.

Participants will learn to design CRISPR based solutions to target genetic disorders. They will learn how to use bioinformatics tools to design guideRNA and repair templates used in CRISPR based gene editing. They will also learn to design CRISPR based Knock-out, Knock-in, knock-down and knock-up of specific genes. Further they will learn software tools that offers fast and reliable analysis of CRISPR editing data.

Student: Bachelor, Masters, PhD, MBBS, MD students as well as Faculty and Professors from Microbiology, Biochemistry, Biotechnology, Immunology, Medicine, Pharmacy, Pharmaceutical Chemistry, Biomedical Technology, Genetics, Bioinformatics, Plant Science and Life Sciences.

Professionals: Resident Doctors, Biotechnology, Bioinformatics, Medicine and Pharmaceutical scientists from industry, academia, and regulatory agencies. Hands-on exercises will be performed individually using software tools on your own laptops. (no prior experience required).

Dr. Shahul Hameed is a researcher and his research involves developing CRISPR based gene therapy for Muscular dystrophy and Sickle Cell Anaemia. He is also involved in the development of novel delivery systems for gene therapy. His research interest extends to design of mRNA based therapeutics and design of Artificial Intelligence based Digital health & Imaging tools. In Collaboration with Dystrophy Annihilation Research Trust, his lab was involved in gene editing of DMD gene for development of CRISPR based therapeutics. [Nov 2018 to Aug 2022]

He has worked as Senior Assistant Professor at B.S. Abdur Rahman Crescent University, Chennai and earlier at Bannari Amman Institute of Technology, Erode. He was involved in teaching biotechnology subjects like Protein Engineering, Genomics and Proteomics, Structural Biology, Pharmaceutical Biotechnology, Genetic Engineering and Chemical Reaction Engineering to students. His research work involved Drug Design against S100A4 oncoprotein. Further development of Machine Learning based tools for predicting thermodynamic stability of enzyme mutants. He was selected through ERASMUS to conduct workshops on drug design and protein engineering at University of Nottingham, UK.

He is a PhD in Biological Sciences from Indian Institute of Science(IISc), Bangalore. At IISc, his research work involved Protein Engineering and Structural Characterization of the engineered mutants using Nuclear magnetic resonance spectroscopy and other biophysical methods. His research work also involved characterization of Protein-Protein interactions using experimental techniques, like NMR and Mass spectrometry, genetic engineering and Computer simulations.

He did his postdoctoral training at Tata Institute of Fundamental Research, Mumbai. There his work involved development of novel NMR techniques to study huge protein complexes. His work also involved Cloning, Protein Expression and Purification of motor proteins.